IHU Liryc
IHU Liryc is a French non-profit academic medical research institute developing personalized digital twin heart models combining MRI, electrical, and conduction velocity data to improve atrial fibrillation treatment planning for cardiac rhythm disease patients.
- Company typePrivate
- Founded2011
- HeadquartersPessac, France
- Headcount51–100
- GTM typeB2B
- OfferingServices
What IHU Liryc does
IHU Liryc is a French non-profit academic medical research institute (Institut Hospitalo-Universitaire) founded in 2011 and headquartered in Pessac, France, with 51-100 employees. The institute focuses on cardiac rhythm diseases, with primary research activity in electrophysiology and computational cardiac modeling. Its primary patient population consists of individuals suffering from atrial fibrillation and heart failure, though the institute does not provide direct clinical care to these patients.
IHU Liryc's core technology is the development of personalized digital twin models of patients' hearts for atrial fibrillation treatment planning. These hybrid models integrate three distinct clinical data streams: MRI scans, electrical voltage measurements, and conduction velocity data. According to published research in the Journal of Physiology, the multi-modal hybrid approach identifies more ablation targets than MRI-only analysis, supporting more accurate treatment planning for persistent atrial fibrillation. Beyond digital twin research, the institute operates telemonitoring programs for heart failure patient follow-up, with leadership from cardiologists Dr. Mélèze Hocini (interim CEO) and Dr. Sylvain Ploux (CHU de Bordeaux).
The institute operates a non-commercial revenue model funded through charitable donations, academic research grants, and institutional partnerships. It collaborates closely with CHU de Bordeaux for clinical translation and with Queen Mary University of London for international research validation. Outreach is conducted via the 'Rencontres Connectées' educational webinar series and the institute's public website. There is no commercial pricing model, no commercial product distribution, and no disclosed revenue figures.
IHU Liryc firmographics
Firmographics- Name
- IHU Liryc
- Website
- https://ihu-liryc.fr
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- IHU Liryc is a French non-profit academic medical research institute developing personalized digital twin heart models combining MRI, electrical, and conduction velocity data to improve atrial fibrillation treatment planning for cardiac rhythm disease patients.
- Ownership category
- akta.pro rank
IHU Liryc industry classification
Industry- Product category
- Cardiac Electrophysiology Research
- NAICS
- Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
- akta.pro secondary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
Keywords
Where IHU Liryc is headquartered
LocationHeadquarters
- HQ city
- Pessac
- HQ country
- France
- HQ region
- Europe
Markets served
IHU Liryc business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Donations and Research Funding: IHU Liryc is funded through charitable donations ('Par votre générosité, vous donnez les moyens aux médecins et chercheurs de Liryc') which enable physicians and researchers to advance cardiac rhythm disease treatment for patients worldwide. Additional funding likely comes from academic research grants and institutional partnerships.
Go-to-market motion1 record
Marketing channels2 records
IHU Liryc product offering
Product offeringCore offering
IHU Liryc is a French university hospital research institute (Institut Hospitalo-Universitaire) that develops personalized digital twin heart models combining MRI scans, electrical voltage measurements, and conduction velocity data to improve atrial fibrillation treatment planning. The institute also operates telemonitoring programs for heart failure patients and disseminates cardiac rhythm disease research through clinical collaborations, academic publications, and educational events.
Product overview
IHU Liryc is a cardiac rhythm institute focused on heart rhythm diseases research and treatment. The institute develops and applies digital twin heart modeling technology for personalized atrial fibrillation treatment planning. In addition to digital twin research, IHU Liryc conducts tele-monitoring programs for heart failure patient follow-up, offering connected health services through specialized cardiology consultations featuring experts like Dre Mélèze Hocini and Dr Sylvain Ploux.
Differentiator
Problem solved
Functional benefit
Products and services
- Digital Heart Twin Models Personalized computational models of individual patients' hearts that simulate cardiac electrical activity to improve treatment planning for atrial fibrillation. The models integrate MRI scan data, electrical voltage measurements, and conduction velocity data to identify optimal ablation targets; currently in research phase, not yet part of routine clinical care.
- Heart Failure Telemonitoring Program Connected health telemonitoring services for heart failure patient follow-up, delivered through clinical collaboration with partner hospitals (notably CHU de Bordeaux) and showcased in the Rencontres Connectées educational series with experts such as Dre Mélèze Hocini and Dr Sylvain Ploux.
Quantifiable outcome
- Hybrid digital twin models identify more ablation targets than MRI data alone
Companies that use IHU Liryc
Customer profileSegments1 record
Ideal customer profiles2 records
IHU Liryc technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature1 record
IHU Liryc partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Queen Mary University of LondoncoreInternational research collaboration with Queen Mary University of London researchers leading the cross-university study on digital twin heart models for atrial fibrillation treatment. Published in the Journal of Physiology, this partnership demonstrates the institute's role as a key contributor to cutting-edge cardiac research combining MRI, electrical voltage, and conduction velocity data.
- CHU de BordeauxcoreClinical collaboration with CHU de Bordeaux hospital where Dr. Sylvain Ploux, cardiologist, participates in institute events and research. The partnership enables translation of research into clinical practice, particularly in telemonitoring and heart failure management.
Recent moves5 records
Expansion highlights4 records
IHU Liryc competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: GE HealthCare offers cardiac imaging, monitoring, and digital solutions across the cardiology workflow. It is a broad incumbent with overlapping capabilities in cardiac diagnostics and digital cardiology tools.
- Siemens Healthineers: Siemens Healthineers is a major incumbent in cardiac imaging, diagnostics, and digital health. It provides overlapping capabilities in cardiovascular diagnostics and computational cardiac analysis as part of a much broader portfolio.
- Philips: Philips provides cardiac imaging, patient monitoring, and connected care solutions for cardiology. It is a broad incumbent whose cardiology portfolio intersects with IHU Liryc's research areas in cardiac imaging and telemonitoring.
Emerging players
- Volta Medical: Volta Medical develops AI-based decision-support tools for cardiac electrophysiologists treating atrial fibrillation. It overlaps directly with IHU Liryc's AF treatment planning mission and represents a commercial peer pursuing AI-enabled electrophysiology.
- InHeart: InHeart is a France-based company building AI-driven personalized cardiac digital twin models for ventricular tachycardia and other arrhythmia treatment planning. It is highly comparable to IHU Liryc given its focus on cardiac computational models for ablation and its French origin.
- CardioSolv: CardioSolv is focused on computational cardiac modeling and simulation for ablation therapy planning. It is a niche emerging player in cardiac digital twin technology for arrhythmia treatment, comparable in scope to IHU Liryc's digital heart twin research.
Direct peers
- Acutus Medical: Acutus Medical develops cardiac mapping and ablation technologies for arrhythmia treatment. Its focus on electrophysiology mapping and ablation workflow makes it directly comparable to IHU Liryc's atrial fibrillation treatment planning research.
- HeartFlow: HeartFlow develops non-invasive coronary digital heart models (FFR-CT) for personalized cardiac diagnostics and treatment planning. It is the closest commercial analog to IHU Liryc's digital twin approach, focused on cardiology computational modeling to guide clinical decisions.
Regional players
- Inria: Inria is the French national institute for digital science research with active cardiac modeling teams (e.g., Carmen team). It is a regional research peer with overlapping cardiac digital twin and electrophysiology modeling research in France.
- Inserm: Inserm is the French national institute for health and medical research, with cardiac electrophysiology research programs. It is a French research peer that conducts complementary cardiovascular and arrhythmia research within the same public research ecosystem.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
IHU Liryc social profiles
Digital presenceIHU Liryc financial estimates
Financial estimateRevenue estimate
Valuation estimate
IHU Liryc leadership team
Management profileNumber of profiles
Profiles1 record
IHU Liryc funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IHU Liryc M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IHU Liryc
What does IHU Liryc do?
IHU Liryc is a French university hospital research institute (Institut Hospitalo-Universitaire) that develops personalized digital twin heart models combining MRI scans, electrical voltage measurements, and conduction velocity data to improve atrial fibrillation treatment planning. The institute also operates telemonitoring programs for heart failure patients and disseminates cardiac rhythm disease research through clinical collaborations, academic publications, and educational events.
Is IHU Liryc a public or private company?
IHU Liryc is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was IHU Liryc founded?
IHU Liryc was founded in 2011. It employs 51 to 100 people.
Where is IHU Liryc based?
IHU Liryc is headquartered in Pessac, France, in the Europe region.
How does IHU Liryc make money?
One revenue line is on record: donations and Research Funding.
Who are IHU Liryc's main competitors?
Broad incumbents on record are GE HealthCare, Siemens Healthineers and Philips. Emerging players are Volta Medical, InHeart and CardioSolv. Direct peers are Acutus Medical and HeartFlow. Regional players are Inria and Inserm.
Does IHU Liryc have an API?
No public API is recorded for IHU Liryc.
What industry is IHU Liryc in?
IHU Liryc's product category is Cardiac Electrophysiology Research. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 5417 and its SIC code is 8731.